
Michael S. Radin MD
Diabetes
Assistant Professor, Medicine, SUNY Stony Brook
Join to View Full Profile
101 Mineola Blvd2nd FloorMineola, NY 11501
Phone+1 516-663-3511
Fax+1 516-663-4780
Dr. Radin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UPMC Medical EducationFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2005
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1999 - 2002
- Uconn School Of MedicineClass of 1999
Certifications & Licensure
- NY State Medical License 2010 - 2025
- CT State Medical License 2005 - 2010
- PA State Medical License 2002 - 2006
- VA State Medical License 1999 - 2002
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 7 citationsChanging to Basal-Bolus Insulin Therapy for the Inpatient Management of Hyperglycemia—A Natural ExperimentDonald A. Brand, Virginia Peragallo-Dittko, Melissa Fazzari, Shahidul Islam, Alan M. Jacobson
Endocrine Practice. 2019-05-09 - 14 citationsβ-Cell death is decreased in women with gestational diabetes mellitus.Lauren A. Kenna, John A. Olsen, Michael G. Spelios, Michael S. Radin, Eitan M. Akirav
Diabetology & Metabolic Syndrome. 2016-08-24 - 121 citationsPitfalls in Hemoglobin A1c Measurement: When Results may be MisleadingMichael S. Radin
Journal of General Internal Medicine. 2014-02-01
Press Mentions
- ‘A Practice-Changing Trial’: Semaglutide Linked to Key Benefits for PAD Patients with DiabetesMarch 29th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: